QURE - Latest News
uniQure N.V. (QURE), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.82B. Beta to the broader market is 0.87.
The article list below shows the most recent QURE headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent QURE Headlines
UniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In Play
seekingalpha.com - May 12, 2026
UniQure is upgraded from Hold to Buy, driven by near-term UK approval prospects for AMT-130 and a robust cash runway to 2029. Despite FDA requiring a
uniQure N.V. (QURE) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 5, 2026
uniQure N. V.
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
zacks.com - May 5, 2026
uniQure (QURE) came out with a quarterly loss of $0. 85 per share versus the Zacks Consensus Estimate of a loss of $0.
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
globenewswire.com - May 5, 2026
~ Advancing FDA interactions on AMT-130 for Huntington's disease; Type B meeting scheduled for the second quarter of 2026 ~
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease
globenewswire.com - Apr 30, 2026
~ Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~
How News Affects QURE Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track QURE's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked QURE news questions
- What is the latest QURE news headline?
- The most recent QURE headline (May 12, 2026) is "UniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In Play". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the QURE news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What QURE news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual QURE options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.